Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs

J Orthop Res. 2012 May;30(5):673-8. doi: 10.1002/jor.22003. Epub 2011 Nov 4.

Abstract

Histological and molecular changes were examined to investigate the effects of long-term administration of glucosamine (GlcN) and chondroitin sulfate (CS) in a model of spontaneous osteoarthritis (OA) in Hartley guinea pigs. Three groups of female 3-week-old Hartley guinea pigs received GlcN, CS, and neither agent, respectively. Five animals in each group were sacrificed at 8, 12, and 18 months of age. At 8 months of age, Hartley guinea pigs had severe degeneration of knee joint cartilage, chondrocyte apoptosis, marked reduction of tissue total RNA, decreases of aggrecan and collagen type 2 mRNAs, and increases in MMP-3 and MMP-8 mRNAs. Long-term administration of GlcN and CS reduced cartilage degeneration at 8 months of age. The marked loss of total RNA and the increase in MMP-3 mRNA were also inhibited by GlcN and CS. Thus, long-term oral administration of GlcN or CS inhibits OA progression, maintains total RNA and down-regulates MMP-3 mRNA in a spontaneous OA model in Hartley guinea pigs.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / pathology
  • Chondrocytes / drug effects*
  • Chondroitin Sulfates / administration & dosage*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Female
  • Glucosamine / administration & dosage*
  • Guinea Pigs
  • Matrix Metalloproteinase 3 / metabolism*
  • Osteoarthritis / drug therapy*
  • Osteoarthritis / pathology
  • RNA, Messenger / metabolism
  • Up-Regulation / drug effects

Substances

  • RNA, Messenger
  • Chondroitin Sulfates
  • Matrix Metalloproteinase 3
  • Glucosamine